By this final point in the follow-up, 26 eyes remained as dry AMD, two of them had started intravitreal pegcetacoplan injections, and one eye had converted to wet AMD and was initiated on anti-vascular endothelial growth factor (VEGF) injections. The gene discussed is VEGFA; the disease is wet macular degeneration.